Profile

Dr (MD, PhD) Wakiro Sato

National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan

Presentation

9:50 CEST / Session: Treatment I: Clinical trials targeting autoantibodies

Rituximab trial in ME/CFS

Dr Wakiro Sato is an adjunct scientist at the National Institute of Neuroscience' s Department of Immunology at the National Center of Neurology and Psychiatry (NCNP) in Toyko, Japan. Dr Sato majored in internal medicine and neurology at Kobe City Central Citizen Hospital. After becoming a neurologist, he began researching multiple sclerosis at the Immune Research Department of the National Institute of Neurology of the National Center for Psychiatry and Neurological Sciences. Dr Sator obtained a doctorate in medicine by analyzing lymphocytes related to pathology, and in particular by conducting research on chemokine receptors in T cells. He was a post-doctoral fellow with the Max Planck Institute of Neurobiology's Department of Neuroimmunology in Munich, Germany. Since 2023, he serves as the Chief of Section of research and development strategy at the Translational Medical Center at NCNP. Dr Sato's work on ME/CFS centres on the investigation of brain abnormalities and alterations in relation to autoimmunity, in an effort to uncover the potential immunopathogenesis in ME/CFS patients.

Wakiro Sato